Anthera Pharmaceuticals, Inc.
ANTH
ANTH was delisted on the 27th of June, 2018.
72 hedge funds and large institutions have $10.8M invested in Anthera Pharmaceuticals, Inc. in 2016 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 25 increasing their positions, 19 reducing their positions, and 11 closing their positions.
32% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 19
18% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 11
0% more funds holding
Funds holding: 72 → 72 (0)
45% less call options, than puts
Call options by funds: $91K | Put options by funds: $164K
84% less capital invested
Capital invested by funds: $67M → $10.8M (-$56.2M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$782K |
| 2 |
A
Abingworth
London,
United Kingdom
|
+$757K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$539K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$533K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$482K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAI
ProQuest Associates IV
Naples,
Florida
|
-$5.99M |
| 2 |
PA
Perceptive Advisors
New York
|
-$4.6M |
| 3 |
BC
Broadfin Capital
New York
|
-$3.64M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.41M |
| 5 |
SCM
Sio Capital Management
New York
|
-$2.84M |
ANTH Hedge Fund Activity: Q4 2016 in Review
72 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Anthera Pharmaceuticals, Inc. (ANTH) for Q4 2016, worth a combined $10.8M — down 84% from $67M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new ANTH positions and 11 closed out — a net gain of 2 holders — while 25 added to existing stakes and 19 trimmed.
The largest buyer was Millennium Management, adding an estimated $782K. The largest seller was ProQuest Associates IV, exiting entirely with an estimated $5.99M sold.
- 72 institutional investors held Anthera Pharmaceuticals, Inc. (ANTH) as of Q4 2016, unchanged from Q3 2016.
- Funds reported $10.8M of Anthera Pharmaceuticals, Inc. stock for Q4 2016, down 84% quarter-over-quarter.
- 13 funds opened new Anthera Pharmaceuticals, Inc. positions in Q4 2016 and 11 closed out, a net change of +2 holders.
- The largest Anthera Pharmaceuticals, Inc. buyer in Q4 2016 was Millennium Management, an estimated $782K added.
- The largest Anthera Pharmaceuticals, Inc. seller in Q4 2016 was ProQuest Associates IV, an estimated $5.99M sold.
Based on aggregated 13F filings for Q4 2016.